Potent T cell‐mediated anti‐inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis

M Tiberi, T Evron, S Saracini, L Boffa… - Neuropathology and …, 2022 - Wiley Online Library
Background Lenabasum is a synthetic cannabinoid receptor type‐2 (CB2) agonist able to
exert potent anti‐inflammatory effects, but its role on T cells remains unknown. Objectives …

Potent T cell‐mediated anti‐inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis.

M Tiberi, T Evron, S Saracini, L Boffa… - Neuropathology & …, 2022 - search.ebscohost.com
Background: Lenabasum is a synthetic cannabinoid receptor type‐2 (CB2) agonist able to
exert potent anti‐inflammatory effects, but its role on T cells remains unknown. Objectives …

Potent T cell-mediated anti-inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis.

M Tiberi, T Evron, S Saracini, L Boffa… - Neuropathology and …, 2021 - europepmc.org
Background Lenabasum is a synthetic cannabinoid receptor type-2 (CB2) agonist able to
exert potent anti-inflammatory effects, but its role on T cells remains unknown. Objectives …

Potent T cell-mediated anti-inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis

M Tiberi, T Evron, S Saracini, L Boffa… - Neuropathology …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Lenabasum is a synthetic cannabinoid receptor type-2 (CB2) agonist able to
exert potent anti-inflammatory effects, but its role on T cells remains unknown. Objectives …